493 related articles for article (PubMed ID: 8555650)
1. Experimental study on safety for granulopoiesis in simultaneous therapy with recombinant human granulocyte colony-stimulating factor and chemotherapy.
Kabaya K; Obuchi M; Watanabe M; Kusaka M; Seki M
Oncol Res; 1995; 7(3-4):165-71. PubMed ID: 8555650
[TBL] [Abstract][Full Text] [Related]
2. Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
Fulton R; Gasper PW; Ogilvie GK; Boone TC; Dornsife RE
Exp Hematol; 1991 Sep; 19(8):759-67. PubMed ID: 1714401
[TBL] [Abstract][Full Text] [Related]
3. Influence of rhG-CSF scheduling on megakaryocytopoietic recovery following 5-fluorouracil-induced hematotoxicity in splenectomized B6D2F1 mice.
Scheding S; Media JE; Nakeff A
Stem Cells; 1998; 16(2):144-51. PubMed ID: 9554039
[TBL] [Abstract][Full Text] [Related]
4. Effect of recombinant human granulocyte colony-stimulating factor on variations of morphologically identifiable bone marrow cells in myelosuppressed mice.
Kabaya K; Kusaka M; Seki M
In Vivo; 1994; 8(6):1033-9. PubMed ID: 7539636
[TBL] [Abstract][Full Text] [Related]
5. Long survival of leukemic mice by repeated combination treatment of cyclophosphamide and recombinant human granulocyte colony-stimulating factor.
Tamura M; Nomura H; Ono M; Bessho M; Hirashima K
Leukemia; 1991 Dec; 5(12):1043-9. PubMed ID: 1723131
[TBL] [Abstract][Full Text] [Related]
6. [Effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) in patients receiving chemotherapy--phase I study].
Fukutani H; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nagamine D; Shinagawa K; Tabata M; Hirano A; Mizunuma N
Gan To Kagaku Ryoho; 1989 May; 16(5):2005-12. PubMed ID: 2471461
[TBL] [Abstract][Full Text] [Related]
7. Effect of recombinant human granulocyte colony-stimulating factor on efficacy of radiation therapy in tumor-bearing rats.
Kabaya K; Watanabe M; Kusaka M; Akahori H; Seki M; Fushiki M
Radiat Res; 1994 Jul; 139(1):92-6. PubMed ID: 7517051
[TBL] [Abstract][Full Text] [Related]
8. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human interleukin-3 (rhIL-3) enhances the mobilization of peripheral blood progenitor cells by recombinant human granulocyte colony-stimulating factor (rhG-CSF) in normal volunteers.
Huhn RD; Yurkow EJ; Tushinski R; Clarke L; Sturgill MG; Hoffman R; Sheay W; Cody R; Philipp C; Resta D; George M
Exp Hematol; 1996 Jun; 24(7):839-47. PubMed ID: 8647235
[TBL] [Abstract][Full Text] [Related]
10. [Promotive effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on recovery from neutropenia induced by fractionated irradiation in mice].
Kabaya K; Watanabe M; Kusaka M; Seki M; Fushiki M
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Aug; 54(9):908-16. PubMed ID: 7524017
[TBL] [Abstract][Full Text] [Related]
11. Sequential administration of interleukin-6 and granulocyte-colony stimulating factor in newborn rats: modulation of newborn granulopoiesis and thrombopoiesis.
Cairo MS; Plunkett JM; Nguyen A; Clark S; van de Ven C
Pediatr Res; 1991 Dec; 30(6):554-9. PubMed ID: 1725208
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
[TBL] [Abstract][Full Text] [Related]
13. [Application of CSF to cancer treatment].
Takaku F
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):739-46. PubMed ID: 2455478
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
[TBL] [Abstract][Full Text] [Related]
15. Effects of granulocyte colony-stimulating factor on hematopoietic injury induced by anticancer drugs in mice.
Mizushima Y; Morikage T; Kuwahara T; Yano S
J Biol Response Mod; 1990 Dec; 9(6):576-83. PubMed ID: 1705961
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on generation and mobilization of neutrophils in cyclophosphamide-treated neutropenic mice.
Hattori K; Orita T; Oheda M; Tamura M; Ono M
In Vivo; 1996; 10(3):319-27. PubMed ID: 8797034
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
[TBL] [Abstract][Full Text] [Related]
18. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
Sai M; Kawanishi Y; Kuriyama K; Kuratsuji T; Toyama K
Rinsho Ketsueki; 1990 Apr; 31(4):484-6. PubMed ID: 1696326
[TBL] [Abstract][Full Text] [Related]
19. [In vivo effects on human neutrophils by administration of rhG-CSF and clinical significance].
Okabe M; Saiki I; Nakane K; Miyazaki T
Rinsho Byori; 1992 Apr; 40(4):397-402. PubMed ID: 1375667
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human granulocyte-colony stimulating factor: in vitro and in vivo effects on myelopoiesis.
Welte K; Bonilla MA; Gabrilove JL; Gillio AP; Potter GK; Moore MA; O'Reilly RJ; Boone TC; Souza LM
Blood Cells; 1987; 13(1-2):17-30. PubMed ID: 3311216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
